683 Capital Management »

Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by 683 Capital Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Mirum Pharmaceuticals Inc Note 4.000 5/0

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals Inc Note 4.000 5/0 held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals Inc Note 4.000 5/0 by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 1.0M 1.47
2024-06-30 $1.4M 1.0M 1.35

More positions owned by 683 Capital Management

Eli Lilly & Co. Put Option (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Ero Copper Corp (ERO)
Hilton Grand Vacations (HGV)
Carvana Cl A (CVNA)
Insmed Note 0.750% 6/0 (Principal)
Wave Life Sciences SHS (WVE)
Alnylam Pharmaceuticals Put Option (ALNY)
Cogent Communications Hldgs Com New (CCOI)
Tg Therapeutics (TGTX)
BorgWarner (BWA)
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Viking Therapeutics (VKTX)

View all positions for 683 Capital Management

Top funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0

Deerfield Management Company
Wolverine Asset Management
Readystate Asset Management
MacKay Shields
Franklin Resources
Point72 Asset Management
SSI Investment Management
Advent Capital Management
Lazard Asset Management
Bnp Paribas Arbitrage, Snc
BlackRock
BlackRock
Nicholas Investments Partners
Bank of America Corporation
Kornitzer Capital Management

View all funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0